SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367920-22-000065
Filing Date
2022-08-22
Accepted
2022-08-22 07:12:06
Documents
12
Period of Report
2022-08-16
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K cnce-20220816.htm   iXBRL 8-K 37902
  Complete submission text file 0001367920-22-000065.txt   177725

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20220816.xsd EX-101.SCH 1917
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20220816_lab.xml EX-101.LAB 24791
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20220816_pre.xml EX-101.PRE 13056
6 EXTRACTED XBRL INSTANCE DOCUMENT cnce-20220816_htm.xml XML 11579
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36310 | Film No.: 221182211
SIC: 2834 Pharmaceutical Preparations